How does the IC-8 IOL provide this range of benefits? In addition, this unique IOL can reduce the effects of both lower and higher order aberrations (HOA), including corneal HOAs such as coma, based on the small aperture effect. The design of the IC-8 IOL enables it to provide 3.00 D of extended depth of focus (EDOF), tolerate up to 1.00 D deviation from the target manifest refraction spherical equivalent, and accommodate as much as 1.50 D of corneal astigmatism (1-4). We asked a panel of surgeons (see sidebar) to share their knowledge and experience of the IC-8 IOL. The IC-8 one-piece hydrophobic acrylic IOL is designed to compensate for the focal consequences of peripheral defocused light, thereby enabling correction of presbyopia with a broad, continuous range of focus (Figure 1). I was surprised to see such good results from such a simple optical principle. Has implanted ~50 IC-8 IOLs since 2016, including in post-laser vision correction patients, postkeratotomy patients, refractive lens exchange and cataract patients. Sathish Srinivasan (UK): Primarily treats cornea, cataract, and refractive patients.Has implanted ~70 IC-8 IOLs, including bilateral IC-8 IOL implantation in irregular cornea patients, since 2018. Michael Shiu (Australia): Mainly treats cataract, glaucoma, and lens exchange patients some AMD.Jacqueline Beltz (Australia): Focuses on cornea, cataract, and refractive patients recently completed a comparison of the IC-8 IOL versus moderate monovision with monofocal IOLs in 40 patients.He has also implanted the IC-8 lens in combination with the Oculentis MF 20 lens. Gerd Auffarth (Germany): Treats a complete spectrum of eye diseases since 2015, has implanted the IC-8 IOL in a broad range of patients including cataract, refractive lens exchange, compromised corneas, and traumatic iris defects.He has also evaluated use of the IC-8 IOL in combination with other EDOF lenses – Symfony/Symfony toric. Has implanted the IC-8 IOL in over 100 cataract patients including those presenting with irregular astigmatism, and significant nocturnal glare. Christopher Chan (Australia): General/refractive ophthalmologist treating primarily glaucoma, AMD, DR, dry eye and cataracts.Has implanted the IC-8 IOL in ~80 patients since 2016. Brendan Vote (Australia): General ophthalmologist with interests in cataract and retina performs 750-1,000 cataract procedures per year.He began implanting the IC-8 IOL in 2016.
Boon Ham (Australia): General/pediatric ophthalmologist with interest in cataract/glaucoma surgery.